Cancer cells use self-inflicted DNA breaks to evade growth limits imposed by genotoxic stress
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Cancer cells use self-inflicted DNA breaks to evade growth limits imposed by genotoxic stress. / Larsen, Brian D; Benada, Jan; Yung, Philip Yuk Kwong; Bell, Ryan A V; Pappas, George; Urban, Vaclav; Ahlskog, Johanna K; Kuo, Tia T; Janscak, Pavel; Megeney, Lynn A; Elsässer, Simon J; Bartek, Jiri; Sørensen, Claus S.
In: Science, Vol. 376, No. 6592, 2022, p. 476-483.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Cancer cells use self-inflicted DNA breaks to evade growth limits imposed by genotoxic stress
AU - Larsen, Brian D
AU - Benada, Jan
AU - Yung, Philip Yuk Kwong
AU - Bell, Ryan A V
AU - Pappas, George
AU - Urban, Vaclav
AU - Ahlskog, Johanna K
AU - Kuo, Tia T
AU - Janscak, Pavel
AU - Megeney, Lynn A
AU - Elsässer, Simon J
AU - Bartek, Jiri
AU - Sørensen, Claus S
PY - 2022
Y1 - 2022
N2 - Genotoxic therapy such as radiation serves as a frontline cancer treatment, yet acquired resistance that leads to tumor reoccurrence is frequent. We found that cancer cells maintain viability during irradiation by reversibly increasing genome-wide DNA breaks, thereby limiting premature mitotic progression. We identify caspase-activated DNase (CAD) as the nuclease inflicting these de novo DNA lesions at defined loci, which are in proximity to chromatin-modifying CCCTC-binding factor (CTCF) sites. CAD nuclease activity is governed through phosphorylation by DNA damage response kinases, independent of caspase activity. In turn, loss of CAD activity impairs cell fate decisions, rendering cancer cells vulnerable to radiation-induced DNA double-strand breaks. Our observations highlight a cancer-selective survival adaptation, whereby tumor cells deploy regulated DNA breaks to delimit the detrimental effects of therapy-evoked DNA damage.
AB - Genotoxic therapy such as radiation serves as a frontline cancer treatment, yet acquired resistance that leads to tumor reoccurrence is frequent. We found that cancer cells maintain viability during irradiation by reversibly increasing genome-wide DNA breaks, thereby limiting premature mitotic progression. We identify caspase-activated DNase (CAD) as the nuclease inflicting these de novo DNA lesions at defined loci, which are in proximity to chromatin-modifying CCCTC-binding factor (CTCF) sites. CAD nuclease activity is governed through phosphorylation by DNA damage response kinases, independent of caspase activity. In turn, loss of CAD activity impairs cell fate decisions, rendering cancer cells vulnerable to radiation-induced DNA double-strand breaks. Our observations highlight a cancer-selective survival adaptation, whereby tumor cells deploy regulated DNA breaks to delimit the detrimental effects of therapy-evoked DNA damage.
KW - Chromatin
KW - DNA/radiation effects
KW - DNA Breaks, Double-Stranded
KW - DNA Damage
KW - DNA Repair
KW - Neoplasms/genetics
U2 - 10.1126/science.abi6378
DO - 10.1126/science.abi6378
M3 - Journal article
C2 - 35482866
VL - 376
SP - 476
EP - 483
JO - Science
JF - Science
SN - 0036-8075
IS - 6592
ER -
ID: 305998791